IL6 and cancer: In the 1970s, although there was not yet a methodology with sufficient sensitivity to measure these cytokines in cancer patients and obtain consistent results, treatment with anti-TNF- and IL-6 antibodies was proven to be effective in reducing cachexia in mouse tumor models (322).